LAM
ALXN
L2 Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,759
| Closed | -$874K | – | 96 |
|
|
2021
Q2 | $874K | Buy |
4,759
+22
| +0.5% | +$4.04K | 0.81% | 47 |
|
|
2021
Q1 | $724K | Sell |
4,737
-1,106
| -19% | -$169K | 0.75% | 50 |
|
|
2020
Q4 | $913K | Buy |
5,843
+1,725
| +42% | +$270K | 0.63% | 41 |
|
|
2020
Q3 | $471K | Buy |
+4,118
| New | +$471K | 0.38% | 54 |
|